|
The
great Indian outsourcing store
Pharmaceutical companies have been outsourcing many of their
processes to multiple business partners for various reasons
and have been deriving benefits. As more pharma companies
look towards outsourcing, Nandini Patwardhan tries to ascertain
whether outsourcing is the in thing for pharmacos.
Roche
signs Tamiflu sub-licensing agreement
Roche has identified twelve potential partners whose addition
to Roche's global Tamiflu supply network would enhance available
supply. These potential partners will be invited for further
in-depth negotiations.
BSV
gets US patent for its Amphotericin B formulation
Bharat Serums and Vaccines (BSV) received a US patent for
Amphotericin B Emulsion, which is a novel formulation of Amphotericin
B in emulsion formulation. All the excipeints used for this
formulation are USFDA approved for injectable formulations.
Lupin
receives USFDA approval for Cefprozil suspension
Lupin announced that it has received USFDA approval for its
ANDA for Cefprozil Oral Suspension, 125 mg/5 ml and 250 mg/5
ml. Cefprozil is the generic equivalent of Bristol Myers Squibb's
Cefzil.
ERP
at a pharma company
Kemwell has been able to gain better insights into its manufacturing
processes through an ERP deployment. Tighter control on costing
is a big benefit, says Abhinav Singh.
'GLP
compliance costs money'
Known for his expertise on regulatory compliance, Dr Ludwig
Huber, Compliance Fellow of Pharmaceutical Solutions Unit,
Agilent Technologies talks to Sapna Dogra on identifying and
evaluating compliance-related initiatives with the most potential
to benefit customers.
'Branded
products are the Holy Grail for Indian pharma'
Jaswinder Chadha the President, CEO and co-founder of marketRx,
a knowledge process outsourcing (KPO) company, is instrumental
in bringing about cutting-edge analytics and interactive technology
to give pharmaceutical marketing a new dimension. He talks
to Katya Naidu about the importance of knowledge process outsourcing
in the pharma industry.
|
